Back to trial details

Intake questionnaire

Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation

Applying to University of Chicago · Chicago, Illinois

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you between 18 and 75 years old?
2. Have you been diagnosed with Overweight or Obesity?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Chicago for study visits?